Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers - Nature Communications Metastatic triple negative breast cancer (mTNBC) has limited treatments options. Here, this group presents a combination of low-dose cyclophosphamide, anti-CSF1R, and anti-PD-1 therapies to boost immu...

Interested in novel therapies for #TripleNegative #BreastCancer? Drs. D. Pedroza, J Rosen et al have promising new findings. #AntiCSF1R #Immunochemotherapy @natcomms.nature.com #BCMCancerCenter @bcmhouston.bsky.social www.nature.com/articles/s41...